Lasse Kjær

<i>In vivo</i> determination of <i>T</i>₁ and <i>T</i>₂ in the brain of patients with severe but stable multiple sclerosis

Henrik Larsson, Jette Lautrup Frederiksen, Lasse Kjær et al. · Magnetic Resonance in Medicine · 1988 · 130 citations

Neurological Disorder, White Matter, Relaxation Processes +22

Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast

Per S. Jørgensen, Torsten Warming, Kim Wadt Hansen et al. · Thrombosis Research · 2002 · 129 citations

Thrombopoiesis, Thrombosis, Venous Thrombosis +8

Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study

Anders Lindholm Sørensen, Stine Ulrik Mikkelsen, Trine Alma Knudsen et al. · Haematologica · 2019 · 103 citations · Full text

The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

Morten Orebo Holmström, Evelina Martinenaite, Shamaila Munir Ahmad et al. · Leukemia · 2017 · 87 citations

Medicine, Immunology, Immune Checkpoint Inhibitor +8

Texture Analysis in Quantitative MR Imaging

Lasse Kjær, P. Ring, C. Thomsen et al. · Acta Radiologica · 1995 · 62 citations

Engineering, Pathology, Brain Lesion +18